Merck KGaA Consumer Business Could Flourish In The Right Hands – Analysts
This article was originally published in The Tan Sheet
Executive Summary
Merck KGaA's weak consumer health business could be an acquisition target for a larger, more geographically diverse and innovative firm, such as Sanofi-Aventis, according to an analysts' report
You may also be interested in...
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.